Josh Gottheimer bought SpringWorks Therapeutics, Inc. - common stock (SWTX) [ST] (SWTX)
Josh Gottheimer (D-NJ), a U.S. Representative, has disclosed 4 trades in SpringWorks Therapeutics, Inc. - common stock (SWTX) [ST] (SWTX) since 2024, 2 purchases and 2 sales, worth an estimated $32K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Josh Gottheimer bought $1,001 - $15,000 of SpringWorks Therapeutics, Inc. - common stock (SWTX) [ST] (SWTX) on May 9, 2024. Since that trade, SWTX is up +0.00% against the S&P 500 up +43.65%, an outperformance of -43.65%.
Across these filings, Josh Gottheimer has been a balanced trader of SWTX (a buy-to-sell ratio of 1.00). The most recent disclosed SWTX transaction shown was dated July 2, 2025. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Josh Gottheimer's SWTX trades vs the price
SWTX is up +0.00% since Josh Gottheimer bought on May 9, 2024, versus +43.65% for the S&P 500.
Performance since this trade
All Josh Gottheimer SWTX trades
| Traded | Type | Size | Return | Est. profit | |
|---|---|---|---|---|---|
| July 2, 2025 | SELL | $1,001 - $15,000 | N/A | — | |
| July 19, 2024 | BUY | $1,001 - $15,000 | N/A | — | |
| June 18, 2024 | SELL | $1,001 - $15,000 | N/A | — | |
| May 9, 2024 | BUY | $1,001 - $15,000 | N/A | — |
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Josh Gottheimer & SWTX trading FAQ
Is it legal for Josh Gottheimer to trade SpringWorks Therapeutics, Inc. - common stock (SWTX) [ST] (SWTX) stock?
Yes. Members of Congress are allowed to trade individual stocks, including SpringWorks Therapeutics, Inc. - common stock (SWTX) [ST] (SWTX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Josh Gottheimer buy SWTX?
Josh Gottheimer disclosed a purchase of $1,001 - $15,000 of SpringWorks Therapeutics, Inc. - common stock (SWTX) [ST] (SWTX) on May 9, 2024, according to public STOCK Act filings.
How has SWTX performed since Josh Gottheimer's trade?
Since Josh Gottheimer bought SWTX on May 9, 2024, the stock is up +0.00%, versus +43.65% for the S&P 500 over the same period, an outperformance of -43.65%.
How many times has Josh Gottheimer traded SWTX?
Josh Gottheimer has disclosed 4 SWTX trades since 2024 (2 purchases and 2 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional SWTX trades?
Quantellect tracks every disclosed congressional trade in SpringWorks Therapeutics, Inc. - common stock (SWTX) [ST] (SWTX) on the SpringWorks Therapeutics, Inc. - common stock (SWTX) [ST] congressional trading page, which aggregates filings across all members of Congress.
Josh Gottheimer's SWTX tradesAll congressional filings for SpringWorks Therapeutics, Inc. - common stock (SWTX) [ST]Josh Gottheimer's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.